HIPPO Pathway and Cell Proliferation

The HIPPO signaling pathway is a crucial regulator of organ size and cell proliferation. It acts as a tumor suppressor pathway, preventing uncontrolled cell growth and promoting apoptosis when needed. Key components include the kinase cascade ($\text{MST1/2}$ and $\text{LATS1/2}$) and the transcriptional co-activators ($\text{YAP}$ and $\text{TAZ}$).

HIPPO Pathway Regulation

Normally, when the HIPPO pathway is active, the $\text{MST1/2}$ kinases phosphorylate and activate the $\text{LATS1/2}$ kinases. $\text{LATS1/2}$ then phosphorylate $\text{YAP}$ and $\text{TAZ}$. Phosphorylation of $\text{YAP}$ and $\text{TAZ}$ typically leads to their inactivation, often by sequestering them in the cytoplasm or marking them for degradation. In this inactive state, they cannot translocate to the nucleus and activate transcription of genes that promote cell proliferation, such as those regulated by $\text{TEAD}$ transcription factors.

Conversely, when the HIPPO pathway is inactive, $\text{YAP}$ and $\text{TAZ}$ remain dephosphorylated. In their dephosphorylated state, $\text{YAP}$ and $\text{TAZ}$ are active. They translocate to the nucleus and bind to $\text{TEAD}$ transcription factors, leading to the activation of genes that drive cell proliferation and survival. Dysregulation leading to overactivity of $\text{YAP}$ and $\text{TAZ}$ is frequently observed in cancers.

Analyzing Events Supporting Cancer Progression

Cancer progression is characterized by uncontrolled cell proliferation. Therefore, we need to identify events within the HIPPO pathway that would lead to increased cell growth. Let's evaluate the given events:

• A. Activation of $\text{TEADs}$ by phosphorylated $\text{YAP/TAZ}$.

  In the standard model, phosphorylated $\text{YAP/TAZ}$ are inactive and do not activate $\text{TEADs}$. If this event were to occur, it would mean that the inhibitory phosphorylation is somehow leading to activation, which contradicts the typical pathway function but would support proliferation.

• B. Activation of $\text{YAP/TAZ}$ on phosphorylation by $\text{MST/LATS}$.

  In the standard model, phosphorylation of $\text{YAP/TAZ}$ by $\text{MST/LATS}$ leads to their inactivation. This statement suggests phosphorylation causes activation, which is contrary to the established mechanism. If true, this would lead to active $\text{YAP/TAZ}$ and support proliferation, but it misrepresents the pathway.

• C. Activation of $\text{TEADs}$ by dephosphorylated $\text{YAP/TAZ}$.

  This event aligns with the standard mechanism of how active $\text{YAP/TAZ}$ function. Dephosphorylated $\text{YAP/TAZ}$ are the active forms that bind to and activate $\text{TEAD}$ transcription factors, leading to the expression of pro-proliferative genes. This clearly supports cancer progression.

• D. Inactivation of $\text{MST/LATS}$ by repressors.

  The $\text{MST/LATS}$ kinases are upstream inhibitors of $\text{YAP/TAZ}$ activity. If $\text{MST/LATS}$ are inactivated, they cannot phosphorylate $\text{YAP/TAZ}$. This results in an accumulation of dephosphorylated, active $\text{YAP/TAZ}$. Active $\text{YAP/TAZ}$ then promotes cell proliferation. Therefore, inactivation of $\text{MST/LATS}$ strongly supports cancer progression.

Conclusion

Events C and D both describe situations that lead to increased activity of the pro-proliferative arm of the HIPPO pathway, thereby supporting cancer progression. Event D (inactivation of $\text{MST/LATS}$) is an upstream event that causes event C (activation of $\text{TEADs}$ by dephosphorylated $\text{YAP/TAZ}$). Therefore, the combination of C and D represents conditions that would promote uncontrolled cell growth.